Currently out of the existing stock ratings of Roger Song, 41 are a BUY (80.39%), 9 are a HOLD (17.65%), 1 are a SELL (1.96%).

Roger Song

Work Performance Price Targets & Ratings Chart

Analyst Roger Song, currently employed at JEFFERIES, carries an average stock price target met ratio of 34.3% that have a potential upside of 34.72% achieved within 132 days.

Roger Song’s has documented 102 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NKTR, Nektar Therapeutics at 26-Nov-2025.

Wall Street Analyst Roger Song

Analyst best performing recommendations are on REPL (REPLIMUNE GROUP).
The best stock recommendation documented was for REPL (REPLIMUNE GROUP) at 7/22/2025. The price target of $6 was fulfilled within 8 days with a profit of $3.19 (113.52%) receiving and performance score of 141.9.

Average potential price target upside

BCEL Atreca REPL Replimune Group AADI Aadi Bioscience CRVS Corvus Pharmaceuticals CTMX CytomX Therapeutics GLYC GlycoMimetics KNTE Kinnate Biopharma  NKTR Nektar Therapeutics ACRS Aclaris Therapeutics ALT Altimmune NVAX Novavax IGMS IGM Biosciences FNCH Finch Therapeutics Group ICVX Icosavax INO Inovio Pharmaceuticals KURA Kura Oncology BIOA BioAge Labs GPCR Structure Therapeutics American Depositary Shares TRML Tourmaline Bio LVTX LAVA Therapeutics NV

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$1

$0.7 (233.33%)

$4

2 years 4 months 25 days ago
(14-Aug-2023)

0/6 (0%)

$0.49 (96.08%)

Hold

$1

$0.7 (233.33%)

$4

2 years 4 months 28 days ago
(11-Aug-2023)

0/6 (0%)

$0.44 (78.57%)

Buy

$25

2 years 4 months 29 days ago
(11-Aug-2023)

0/4 (0%)

$18.48 (1258.95%)

Buy

$20

2 years 9 months 8 days ago
(31-Mar-2023)

1/3 (33.33%)

$14.51 (264.30%)

220

Buy

$27

3 years 7 months 20 days ago
(19-May-2022)

0/1 (0%)

$18.23 (207.87%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Roger Song is most bullish on?

Potential upside of $77.58 has been obtained for NKTR (NEKTAR THERAPEUTICS)

Which stock is Roger Song is most reserved on?

Potential downside of -$2.9 has been obtained for REPL (REPLIMUNE GROUP)

What Year was the first public recommendation made by Roger Song?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?